FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-β2

Biochemical and Biophysical Research Communications

Volumn 359, Issue 1, 2007, Pages 108-114

  Ito, Tomomi ^a,b   Sawada, Rumi ^a   Fujiwara, Yoko ^b   Seyama, Yousuke ^b   Tsuchiya, Toshie ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b OCHANOMIZU UNIVERSITY   (Japan)

Author keywords

Cellular senescence; Cyclin dependent kinase inhibitors; FGF 2; Human mesenchymal stem cells; RB; TGF

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; TRANSFORMING GROWTH FACTOR BETA2;

ANALYTIC METHOD; ARTICLE; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE;

CELL AGING; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FIBROBLAST GROWTH FACTOR 2; HUMANS; MESENCHYMAL STEM CELLS; TRANSFORMING GROWTH FACTOR BETA2;

EID: 34249661093     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.067     Document Type: Article

References (37)

1. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
2. Caplan A.I., and Bruder S.P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol. Med. 7 (2001) 259-264
3. Gojo S., Gojo N., Takeda Y., Mori T., Abe H., Kyo S., Hata J., and Umezawa A. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp. Cell Res. 288 (2003) 51-59
4. Wakitani S., Saito T., and Caplan A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18 (1995) 1417-1426
5. Darwin J.P. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
6. Ohgushi H., and Caplan A.I. Stem cell technology and bioceramics: from cell to gene engineering. J. Biomed. Mater. Res. 48 (1999) 913-927
7. Petite H., Viateau V., Bensaid W., Meunier A., Pollak C., Bourguignon M., Oudina K., Sedel L., and Guillemin G. Tissue-engineered bone regeneration. Nat. Biotechnol. 18 (2000) 959-963
8. Ochi M., Adachi N., Hiroo N., Yamada S., Ito Y., and Agung M. Articular cartilage repair using tissue engineering technique-novel approach with minimally invasive procedure. Artif. Organs 28 (2004) 28-32
9. Mastrogiacomo M., Cancedda R., and Quarto R. Effect of different growth factors on the chondrogenic potential of human bone marrow stromal cells. Osteoarthritis Cartilage 9 Suppl. A (2001) S36-S40
10. Martin I., Muraglia A., Campanile G., Cancedda R., and Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138 (1997) 4456-4462
11. Bianchi G., Banfi A., Mastrogiacomo M., Notaro R., Luzzatto L., Cancedda R., and Quarto R. Ex vivo enrichment of mesenchymal stem cell progenitors by fibroblast growth factor 2. Exp. Cell Res. 287 (2003) 98-105
12. Solchaga L.A., Penick K., Porter J.D., Goldberg V.M., Caplan A.I., and Welter J.F. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J. Cell Physiol. 203 (2005) 398-409
13. Tsutsumi S., Shimazu A., Miyazaki K., Pan H., Koike C., Yoshida E., Takagishi K., and Kato Y. Retention of multilineage differentiation potential of mesenchymal stem cells during proliferation in response to FGF. Biochem. Biopys. Res. Commun. 288 (2001) 413-419
14. Miyazono K., Suzuki H., and Imamura T. Regulation of TGF-β signaling and its roles in progression of tumors. Cancer Sci. 94 (2003) 230-234
15. Laiho M., DeCaprio J.A., Ludlow J.W., Livingston D.M., and Massague J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62 (1990) 175-185
16. Charles J., and Jeames M.R. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes & Development 13 (1999) 1501-1512
17. Massague J., Blain S.W., and Lo R.S. TGF-β signaling in growth control, cancer, and heritable disorders. Cell 103 (2000) 295-309
18. Zhou W., Park I., Pins M., Kozlowski J.M., Jovanovic B., Zhang J., Lee C., and Ilio K. Dual regulation of proliferation and growth arrest in prostatic stromal cells by transforming growth factor-β1. Endocrinology 144 (2003) 4280-4284
19. Itahana K., Dimri G., and Campisi J. Regulation of cellular senescence by p53. Eur. J. Biochem. 268 (2001) 2784-2791
20. Dimri G.P., Lee X., Basile G., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., Peacocke M., and Campisi J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92 (1995) 9363-9367
21. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
22. LaBaer J., Garrett M.D., Stevenson L.F., Slingerland J.M., Sandhu C., Chou H.S., Fattaey A., and Harlow E. New function activities for the p21 family of CDK inhibitors. Genes. Dev. 11 (1997) 847-862
23. Itahana K., Dimri G.P., Hara E., Itahana Y., Zou Y., Desprez P.Y., and Campisi J. A role for p53 in maintaining and establishing the quiescence growth arrest in human cells. J. Biol. Chem. 277 (2002) 18206-18214
24. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396 (1998) 84-88
25. Rheinwald J.G., Hahn W.C., Ramsey M.R., Wu J.Y., Guo Z., Tsao H., Luca M., Catricala C., and O'Toole K.M. A two-stage, p16 (INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol. Cell Biol. 22 (2002) 5157-5172
26. Beausejour C.M., Krtolica A., Galimi F., Narita M., Lowe S.W., Yaswen P., and Campisi J. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22 (2003) 4212-4222
27. R.Sawada, Ito T., and Tsuchiya T. Changes in expression of genes related to cell proliferation in human mesenchymal stem cells during in vitro culture in comparison with cancer cells. J. Artif. Organs 9 (2006) 179-184
28. Wang D., Park J.S., Chu J.S., Krakowski A., Luo K., Chen D.J., and Li S. Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor β1 stimulation. J. Biol. Chem. 279 (2004) 43725-43734
29. Leskela H.V., Risteli J., Niskanen S., Koivunen J., Ivaska K.K., and Lehenkari P. Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochem. Biopys. Res. Commun. 311 (2003) 1008-1013
30. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., Nomiyama K., Hosokawa K., Sakurada K., Nakagata N., Ikeda Y., Mak T.W., and Suda T. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431 (2004) 997-1002
31. Untergasser G., Gander R., Lilg C., Lepperdinger E.P., and Berger P. Profiling molecular targets of TGF-β1 in prostate fibroblast-to-myofibroblast transdifferentiation. Mech. Ageing Dev. 126 (2005) 59-69
32. Ha. Oncogene 19 (2000) 1698-1709
33. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 81 (1995) 323-330
34. Herrera R.E., Makela T.P., and Weinberg R.A. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol. Biol. Cell. 7 (1996) 1335-1342
35. Yan Z., Hsu S., Winawer S., and Friedman E. Transforming growth factor beta 1 (TGF-beta1) inhibits retinoblastoma gene expression but not pRB phosphorylation in TGF-beta 1-growth stimulated colon carcinoma cells. Oncogene 7 (1992) 801-805
36. Lu J., Lu Z., Reinach P., Zhang J., Dai W., Lu L., and Xu M. TGF-beta2 inhibits AKT activation and FGF-2-induced corneal endothelial cell proliferation. Exp. Cell Res. 312 (2006) 3631-3640
37. Chen Q.M., Tu V.C., and Liu J. Measurements of hydrogen peroxide induced premature senescence: senescence-associated beta-galactosidase and DNA synthesis index in human diploid fibroblasts with down-regulated p53 or Rb. Biogerontology 1 (2000) 335-339